Ginger Ellen Nicol MD CEDS, DABOM
Child & Adolescent Psychiatry
Professor of Psychiatry Director, Center for Holistic Interdisciplinary Research in Psychedelics (CHIRP), Washington University in St. Louis
Join to View Full Profile
600 S Taylor AveSte 121Saint Louis, MO 63110
Phone+1 314-362-5939
Fax+1 314-747-1170
Dr. Nicol is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Ginger Nicol is a psychiatrist and clinical trialist in Saint Louis, MO. She received her medical degree from University of Iowa Carver College of Medicine and has been in practice 15 years. She has expertise in obesity medicine, eating disorders and psychedelic psychiatry.
Education & Training
Washington University in St. Louis School of MedicinePost-Doctoral Fellowship, 2007 - 2010- Washington University/B-JH/SLCH ConsortiumFellowship, Child and Adolescent Psychiatry, 2005 - 2007
- Washington University/B-JH/SLCH ConsortiumResidency, Psychiatry, 2002 - 2005
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 2002
Certifications & Licensure
IL State Medical License 2021 - 2026
MO State Medical License Active through 2026
American Board of Psychiatry and Neurology Psychiatry- American Board of Psychiatry and Neurology Child & Adolescent Psychiatry
American Board of Obesity Medicine Obesity Medicine
International Association of Eating Disorder ProfessionalsCertified Eating Disorder Specialist
Awards, Honors, & Recognition
- Dean’s Impact Award Washington University School of Medicine, 2023
- Mortimer Goodman Mental Health Professional Award National Alliance for the Mentally Ill, 2014
- Eli Robbins Award for Excellence in Clinical Psychiatry, Teaching and Research Washington University Department of Psychiatry, 2007
Clinical Trials
- Metabolic Effects of Antipsychotics in Children Start of enrollment: 2006 Apr 01
- Effects of Antipsychotic Medications on Energy Intake and Expenditure Start of enrollment: 2006 Apr 01
- Biomarkers of Cardiometabolic Risk in Children Treated With Antipsychotics: A Preliminary Study of Direct Measures Start of enrollment: 2010 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Correction: Psilocybin's acute and persistent brain effects: a precision imaging drug trials.Subha Subramanian, Travis Rick Reneau, Demetrius Perry, Ravi Chacko, Timothy O Laumann
Scientific Data. 2025-06-18 - Psilocybin's acute and persistent brain effects: a precision imaging drug trial.Subha Subramanian, Travis Rick Reneau, Demetrius Perry, Ravi Chacko, Timothy O Laumann
Scientific Data. 2025-06-05 - Stimulant medications affect arousal and reward, not attention.Benjamin P Kay, Muriah D Wheelock, Joshua S Siegel, Ryan Raut, Roselyne J Chauvin
Biorxiv. 2025-05-22
Journal Articles
- Cognitive Improvement in Older Adults in the Year After Hip Fracture: Implications for Brain Resilience in Advanced AgingGinger Nicol, Eric J Lenze, The American Journal of Geriatric Psychiatry
- Behavioral Weight Loss Treatment for Youth Treated with Antipsychotic MedicationsGinger E Nicol, Rachel P Kolko, Monica Mills, Thrudur Gunnarsdottir, Michael D Yingling, Julia A Schweiger, Eric J Lenze, John W Newcomer, Denise Wilfley, Scandinavian Journal of Child and Adolescent Psychiatry and Psychology, 5/1/2016
Authored Content
- Cognitive Improvement in Older Adults in the Year After Hip Fracture: Implications for Brain Resilience in Advanced AgingJuly 2018
Press Mentions
Reshaping MindsJune 10th, 2025- Two WashU Medicine Projects Compete in STAT Madness TournamentMarch 6th, 2025
- What to Know About Delta-8 and Other Common Vape Shop DrugsSeptember 3rd, 2024
- Join now to see all
Grant Support
- Biotype-assigned Augmentation Approach in Resistant late life Depression (BAARD)WASHINGTON UNIVERSITY2024–2026
- Biotype-assigned Augmentation Approach in Resistant late life Depression (BAARD)WASHINGTON UNIVERSITY2024–2026
- Biotype-assigned Augmentation Approach in Resistant late life Depression (BAARD)WASHINGTON UNIVERSITY2024–2026
- Biotype-assigned Augmentation Approach in Resistant late life Depression (BAARD)WASHINGTON UNIVERSITY2024–2026
- Discovery and CRISPR validation of genetic factors associated with antipsychotic-induced weight gain and cardiometabolic riskWASHINGTON UNIVERSITY2021–2025
External Links
- Healthy Mind Labhttps://healthymind.wustl.edu/
- Mobile Health Research Corehttps://mhealth.wustl.edu/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
